Total Payments
$9,985
2024 Payments
$1,639
Companies
35
Transactions
439
Medicare Patients
15,426
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$9,297 (93.1%)
Travel$641.95 (6.4%)
Education$46.55 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,297 | 428 | 93.1% |
| Travel and Lodging | $641.95 | 3 | 6.4% |
| Education | $46.55 | 8 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,878 | 75 | $0 (2024) |
| Inspire Medical Systems, Inc. | $1,654 | 13 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,417 | 121 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,315 | 52 | $0 (2024) |
| GENZYME CORPORATION | $1,017 | 43 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $401.59 | 15 | $0 (2024) |
| Electromed, Inc. | $370.22 | 24 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $205.68 | 8 | $0 (2023) |
| Philips Electronics North America Corporation | $174.53 | 6 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $159.15 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,639 | 67 | GENZYME CORPORATION ($469.55) |
| 2023 | $2,155 | 60 | Inspire Medical Systems, Inc. ($862.13) |
| 2022 | $1,531 | 70 | AstraZeneca Pharmaceuticals LP ($298.67) |
| 2021 | $1,593 | 84 | GlaxoSmithKline, LLC. ($348.04) |
| 2020 | $1,349 | 62 | GlaxoSmithKline, LLC. ($369.49) |
| 2019 | $701.54 | 44 | Boehringer Ingelheim Pharmaceuticals, Inc. ($300.83) |
| 2018 | $669.89 | 24 | Boehringer Ingelheim Pharmaceuticals, Inc. ($365.06) |
| 2017 | $347.20 | 28 | Boehringer Ingelheim Pharmaceuticals, Inc. ($235.55) |
All Payment Transactions
439 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.39 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.83 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.90 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/09/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $11.82 | General |
| Category: HFCWO | ||||||
| 10/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: Immunology | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.55 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $52.41 | General |
| Category: NEUROLOGY | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $3.99 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.41 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $17.51 | General |
| Category: HFCWO | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Respiratory | ||||||
| 08/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: RESPIRATORY | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Respiratory | ||||||
| 08/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.91 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/13/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $19.38 | General |
| Category: Medical Device | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: RESPIRATORY | ||||||
| 08/03/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $8.75 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 3,765 | 4,524 | $850,291 | $318,854 |
| 2022 | 26 | 3,443 | 3,841 | $756,919 | $268,270 |
| 2021 | 22 | 3,197 | 3,474 | $663,144 | $235,623 |
| 2020 | 28 | 5,021 | 6,668 | $1.2M | $436,266 |
Total Patients
15,426
Total Services
18,507
Medicare Billing
$1.3M
Procedure Codes
105
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 408 | 622 | $167,940 | $81,514 | 48.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 79 | 84 | $126,000 | $38,069 | 30.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 252 | 295 | $59,000 | $27,517 | 46.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 517 | 621 | $61,479 | $25,636 | 41.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 534 | 647 | $97,050 | $25,178 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 199 | 199 | $62,088 | $24,345 | 39.2% |
| G0398 | Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation | Office | 2023 | 151 | 158 | $55,300 | $23,892 | 43.2% |
| 94660 | Therapy procedure using a positive pressure ventilator | Office | 2023 | 340 | 389 | $45,124 | $16,363 | 36.3% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 25 | 25 | $33,233 | $10,663 | 32.1% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 305 | 356 | $25,988 | $9,935 | 38.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 57 | 89 | $17,622 | $8,330 | 47.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 184 | 185 | $21,460 | $5,260 | 24.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 216 | 241 | $16,147 | $4,728 | 29.3% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 140 | 154 | $18,942 | $3,906 | 20.6% |
| 71045 | X-ray of chest, 1 view | Office | 2023 | 99 | 126 | $7,560 | $2,374 | 31.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $6,192 | $2,249 | 36.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $5,835 | $2,207 | 37.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $5,050 | $1,981 | 39.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 22 | 22 | $2,090 | $1,582 | 75.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $2,280 | $711.84 | 31.2% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 13 | 13 | $7,558 | $543.75 | 7.2% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 11 | 11 | $825.00 | $516.56 | 62.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 30 | 32 | $1,216 | $499.96 | 41.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 38 | $1,672 | $405.46 | 24.3% |
| 94762 | Test to measure oxygen level in blood using ear or finger device continuously overnight | Office | 2023 | 12 | 14 | $630.00 | $207.95 | 33.0% |
About Dr. Dennis Kellar, MD
Dr. Dennis Kellar, MD is a Pulmonary Disease healthcare provider based in Algonquin, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679683866.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dennis Kellar, MD has received a total of $9,985 in payments from pharmaceutical and medical device companies, with $1,639 received in 2024. These payments were reported across 439 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($9,297).
As a Medicare-enrolled provider, Kellar has provided services to 15,426 Medicare beneficiaries, totaling 18,507 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Algonquin, IL
- Active Since 08/30/2006
- Last Updated 12/21/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679683866
Products in Payments
- DUPIXENT (Biological) $1,394
- OFEV (Drug) $1,293
- INSPIRE (Device) $1,079
- TRELEGY ELLIPTA (Drug) $974.59
- Inspire Upper Airway Stimulation System (Device) $575.27
- SMARTVEST (Device) $370.22
- NUCALA (Biological) $292.78
- BREZTRI (Drug) $273.62
- SYMBICORT (Drug) $257.58
- AIRSUPRA (Drug) $186.86
- FASENRA (Biological) $186.54
- XARELTO (Drug) $174.76
- TEZSPIRE (Biological) $173.41
- FARXIGA (Drug) $159.14
- JARDIANCE (Drug) $117.96
- Prolastin-C Liquid (Biological) $112.92
- TRULICITY (Drug) $97.50
- Da Vinci Surgical System (Device) $96.27
- Wakix (Drug) $95.34
- ACTHAR (Biological) $89.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.